Issue 3, 2017

Design, synthesis and evaluation of new ligustrazine derivatives as potential plasma-stable neuroprotective agents

Abstract

A series of ligustrazine–phenolic acid esters which exhibited promising neuroprotective activities have previously been reported. Nevertheless, we found that these ester compounds (like T-VA) were not stable in plasma by further in vivo studies. To investigate plasma-stable neuroprotective agents, a series of new ligustrazine derivatives were synthesized by conjoining ligustrazine and phenols with ester, ether and amide bonds. Most of the compounds exhibited higher protective effects against CoCl2-induced neurotoxicity in differentiated PC12 cells than ligustrazine. Structure–activity relationships were also briefly discussed. We found that compound 2c (2-((2-methoxy-4-(((3,5,6-trimethylpyrazin-2-yl)methoxy) methyl)phenoxy)methyl)-3,5,6-trimethylpyrazine) displayed the highest protective effect on the PC12 cells damaged by CoCl2 (EC50 = 1.07 μM). Preliminary stability investigation in rat plasma was verified in vitro and better plasma stability was observed with 2c in comparison to T-VA.

Graphical abstract: Design, synthesis and evaluation of new ligustrazine derivatives as potential plasma-stable neuroprotective agents

Supplementary files

Article information

Article type
Research Article
Submitted
02 Jan 2017
Accepted
08 Feb 2017
First published
09 Feb 2017

Med. Chem. Commun., 2017,8, 652-656

Design, synthesis and evaluation of new ligustrazine derivatives as potential plasma-stable neuroprotective agents

C. Zhang, W. Yan, R. Zhao, B. Xu, X. Fang, M. Yan, Y. Zhang, P. Wang and H. Lei, Med. Chem. Commun., 2017, 8, 652 DOI: 10.1039/C7MD00003K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements